Spinal cord stimulators have grown in popularity over the past several years as patients see benefits in the less-invasive ...

Nevro NVRO is well-poised for growth in the coming quarters, courtesy of its business expansion plans and restructuring ...

Nevro NVRO is well-poised for growth in ... However, concerns regarding softness in the spinal cord stimulation (SCS) market and dependence on third-party payers persist. This Zacks Rank #2 ...

A 24-month study compared CMM alone versus Nevro’s high-frequency (10 kHz) spinal cord stimulation (SCS) system for treating NSRBP. In April 2024, Medtronic plc, a world leader in medical technology, ...

Nevro Corp. engages in the development of ... It develops and commercializes the senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic ...